Matt Truman
Sydney, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Response to the Letter to the Editor Entitled "Diagnostic Latency and Unmeasured Disease Severity In Male Lupus Nephritis".
Journal: Kidney international reports
Published: March 01, 2026
A Pooled Analysis of Sex Differences in Lupus Nephritis.
Journal: Kidney international reports
Published: September 06, 2025
Long-term safety and efficacy of voclosporin in Asian patients with lupus nephritis: A post hoc analysis of the AURORA 2 trial.
Journal: Modern rheumatology
Published: May 30, 2025
Comparison of a voclosporin-based triple immunosuppressive therapy to high-dose glucocorticoid-based immunosuppressive therapy: a propensity analysis of the AURA-LV and AURORA 1 studies and ALMS.
Journal: Lupus science & medicine
Published: July 15, 2024
Predictors of treatment response in a lupus nephritis population: lessons from the Aspreva Lupus Management Study (ALMS) trial.
Journal: Lupus science & medicine
Published: September 15, 2021
Reasons for Biologic and Targeted Synthetic Disease-modifying Antirheumatic Drug Cessation and Persistence of Second-line Treatment in a Rheumatoid Arthritis Dataset.
Journal: The Journal of rheumatology
Published: November 20, 2019
Comparison of standard of care treatment with a low steroid and mycophenolate mofetil regimen for lupus nephritis in the ALMS and AURA studies.
Journal: Lupus
Published: May 09, 2019
Results From the First Multicenter, Open-label, Phase IIIb Study Investigating the Combination of Pertuzumab With Subcutaneous Trastuzumab and a Taxane in Patients With HER2-positive Metastatic Breast Cancer (SAPPHIRE).
Journal: Clinical breast cancer
Published: September 26, 2018
Safety and Efficacy of Bevacizumab Plus Standard-of-Care Treatment Beyond Disease Progression in Patients With Advanced Non-Small Cell Lung Cancer: The AvaALL Randomized Clinical Trial.
Journal: JAMA oncology
Published: September 05, 2018
Effectiveness of biologics in Australian patients with rheumatoid arthritis: a large observational study: REAL.
Journal: Internal medicine journal
Published: December 21, 2017
Once-Monthly Continuous Erythropoietin Receptor Activator (C.E.R.A.) in Patients with Hemodialysis-Dependent Chronic Kidney Disease: Pooled Data from Phase III Trials.
Journal: Advances in therapy
Published: January 08, 2016
Tumor marker analyses from the phase III, placebo-controlled, FASTACT-2 study of intercalated erlotinib with gemcitabine/platinum in the first-line treatment of advanced non-small-cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: November 30, 2015
Last Updated: 09/26/2026